NeoChord

NeoChord is a biotech company in Maple Grove, United States, founded in 2007. It has raised $40.9M across 5 rounds, most recently a $493K Seed in March 2025.

Transforming Mitral Valve Repair

Employees
11–50
Founded
2007
Business Model
B2B
Total Funding
$40.9M
Last Round
$493K SeedMar 2025
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 6 investors for this company. The full record is or through the API.

About

NeoChord is a privately held medical-technology company developing beating-heart mitral-valve repair for patients with mitral regurgitation. Its flagship NeoChord Artificial Chordae Delivery System provides an echo-guided treatment intended to restore normal mitral-valve function while preserving procedural control and future treatment options. The system received European market clearance in December 2012, while United States law limits it to investigational use.

Summary

It lists 11–50 employees. It has raised $40.9M in total across 5 rounds, most recently a $493K Seed round in Mar 2025. Investors include Deerfield Management, US Venture Partners and Treo Ventures.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
SeedSeed RoundMar 2025
$493K

Sign up to see all 5 events

Funding: Series A through Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

NeoChord on Indexed.vc
<a href="https://indexed.vc/companies/neochord"><img src="https://indexed.vc/api/badge/company/neochord" alt="NeoChord on Indexed.vc" width="260" height="76" /></a>